The Effects of Dual Antiplatelet Therapy on the Occurrence of Recurrent Cardiovascular Events After Myocardial Infarction in Obese Patients

The Effects of Dual Antiplatelet Therapy on the Occurrence of Recurrent Cardiovascular Events After Myocardial Infarction in Obese Patients

Introduction. Acute myocardial infarction (AMI) with ST elevation (STEMI) is still the main cause of mortality and invalidisation of able­bodied population. Regardless of the primary percutaneous coronary intervention (PCI) or thrombolysis, dual antiplatelet therapy (DAPT) remains the main therapeut...

Full description

Bibliographic Details
Main Authors: Borovyk K., Rindina N., Kravchun P., Tabachenko O., Yermak O., Romanyuk M.
Format: Article
Language:English
Published: Publishing House "Kyrylytsya" 2019-04-01
Series:Львівський клінічний вісник
Subjects:
acute myocardial infarction
clopidogrel
dual antiplatelet therapy
obesity
recurrent cardiovascular event
ticagrelor
Online Access:http://lkv.biz/the-effects-of-dual-antiplatelet-therapy-on-the-occurrence-of-recurrent-cardiovascular-events-after-myocardial-infarction-in-obese-patients/

Internet

http://lkv.biz/the-effects-of-dual-antiplatelet-therapy-on-the-occurrence-of-recurrent-cardiovascular-events-after-myocardial-infarction-in-obese-patients/

Similar Items